Ambev Reports 2016 First Quarter Results Under IFRS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall St futures slip as chip stocks drag; Netflix tumbles
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Goldman sees central bank demand providing a floor for gold prices
- Nike out of World Cup contention as Adidas-outfitted teams head to final
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
JPMorgan Downgrades Ambev S.A. (ABEV) to Neutral
May 5, 2016 7:47 AM EDTJPMorgan downgraded Ambev S.A. (NYSE: ABEV) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Ambev S.A. click here. For more ratings news on Ambev S.A. click here.
Shares of Ambev S.A. closed at $5.48 yesterday.
... More